The MarketWatch News Department was not involved in the creation of this content. JUNO BEACH, Fla., Dec. 22, 2025 /PRNewswire/ -- Aqualung Therapeutics, a clinical-stage immunotherapeutics company, ...
JUNO BEACH, Fla., Dec. 22, 2025 /PRNewswire/ -- Aqualung Therapeutics, a clinical-stage immunotherapeutics company, announced today that the Food and Drug Administration (FDA) has cleared its Phase 2a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results